The immune-stimulating particle adjuvant (ISPA) as a versatile adjuvant platform for recombinant vaccines against chronic Toxoplasma gondii infection

Authors:

Abstract
No abstract available
Funding Information
  • Agencia Nacional de Promoción Científica y Tecnológica
  • Fondo para la Investigación Científica y Tecnológica (PICT-2020-SERIE A-02761)

This publication has 28 references indexed in Scilit: